Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.
2.

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review.

Braat MN, Samim M, van den Bosch MA, Lam MG.

Clin Transl Imaging. 2016;4:283-295. Review.

3.

Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.

Elshamy M, Aucejo F, Menon KV, Eghtesad B.

World J Hepatol. 2016 Jul 28;8(21):874-80. doi: 10.4254/wjh.v8.i21.874.

4.

Differentiation of Bone Marrow: Derived Mesenchymal Stem Cells into Hepatocyte-like Cells.

Al Ghrbawy NM, Afify RA, Dyaa N, El Sayed AA.

Indian J Hematol Blood Transfus. 2016 Sep;32(3):276-83. doi: 10.1007/s12288-015-0581-7.

PMID:
27429519
5.

Liver transplantation in acute liver failure: A challenging scenario.

Mendizabal M, Silva MO.

World J Gastroenterol. 2016 Jan 28;22(4):1523-31. doi: 10.3748/wjg.v22.i4.1523. Review.

6.
7.

Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapy.

Jacob R, Saddekni S, Dover L, DuBay DA.

Liver Transpl. 2016 Apr;22(4):547-51. doi: 10.1002/lt.24398. No abstract available.

PMID:
26785388
8.

Chaperones in hepatitis C virus infection.

Khachatoorian R, French SW.

World J Hepatol. 2016 Jan 8;8(1):9-35. doi: 10.4254/wjh.v8.i1.9. Review.

9.

Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Cillo U, Giuliani T, Polacco M, Herrero Manley LM, Crivellari G, Vitale A.

World J Gastroenterol. 2016 Jan 7;22(1):232-52. doi: 10.3748/wjg.v22.i1.232. Review.

10.

Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis.

Cheng Z, Lv Y, Pang S, Bai R, Wang M, Lin S, Xu T, Spalding D, Habib N, Xu R.

Acta Pharm Sin B. 2015 May;5(3):194-200. doi: 10.1016/j.apsb.2015.02.003.

11.

Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Fahrner R, Dondorf F, Ardelt M, Dittmar Y, Settmacher U, Rauchfuß F.

World J Gastroenterol. 2015 Nov 14;21(42):12071-82. doi: 10.3748/wjg.v21.i42.12071. Review.

12.

Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence.

Rahimi RS, Trotter JF.

Ann Gastroenterol. 2015 Jul-Sep;28(3):323-330. Review.

13.

Liver transplantation as a management of hepatocellular carcinoma.

Azzam AZ.

World J Hepatol. 2015 Jun 8;7(10):1347-54. doi: 10.4254/wjh.v7.i10.1347. Review.

14.

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Korean Liver Cancer Study Group (KLCSG).; National Cancer Center, Korea (NCC)..

Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465.

15.

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Korean Liver Cancer Study Group (KLCSG).; National Cancer Center, Korea (NCC)..

Gut Liver. 2015 May 23;9(3):267-317. doi: 10.5009/gnl14460.

16.

Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.

Macdonald B, Sewell JL, Harper AM, Roberts JP, Yao FY.

Clin Transplant. 2015 Jun;29(6):506-12. doi: 10.1111/ctr.12542.

17.

Integration of palliative care in end-stage liver disease and liver transplantation.

Potosek J, Curry M, Buss M, Chittenden E.

J Palliat Med. 2014 Nov;17(11):1271-7. doi: 10.1089/jpm.2013.0167. Review.

18.

Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study.

Fontana RJ, Ellerbe C, Durkalski VE, Rangnekar A, Reddy RK, Stravitz T, McGuire B, Davern T, Reuben A, Liou I, Fix O, Ganger DR, Chung RT, Schilsky M, Han S, Hynan LS, Sanders C, Lee WM; US Acute Liver Failure Study Group..

Liver Int. 2015 Feb;35(2):370-80. doi: 10.1111/liv.12632.

19.

Surgeon general's perspectives.

Lushniak BD.

Public Health Rep. 2014 May;129(3):220-1. No abstract available.

20.

Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008.

Smith BD, Beckett GA, Yartel A, Holtzman D, Patel N, Ward JW.

Am J Public Health. 2014 Mar;104(3):474-81. doi: 10.2105/AJPH.2013.301549.

Items per page

Supplemental Content

Support Center